Cannula and circuit management in peripheral extracorporeal membrane oxygenation: An international survey of 45 countries


Autoři: Taressa Bull aff001;  Amanda Corley aff001;  India Lye aff001;  Amy J. Spooner aff001;  John F. Fraser aff001
Působiště autorů: Critical Care Research Group, The Prince Charles Hospital and University of Queensland, Chermside, Queensland, Australia aff001;  Adult Intensive Care Services, The Prince Charles Hospital, Chermside, Queensland, Australia aff002
Vyšlo v časopise: PLoS ONE 14(12)
Kategorie: Research Article
doi: 10.1371/journal.pone.0227248

Souhrn

Effective and safe practices during extracorporeal membrane oxygenation (ECMO) including infection precautions and securement of lines (cannulas and circuits) are critical to prevent life-threatening patient complications, yet little is known about the practices of bedside clinicians and data to support best practice is lacking. Therefore, the aim of this study was to identify and describe common line-related practices for patients supported by peripheral ECMO worldwide and to highlight any gaps for further investigation. An electronic survey was conducted to examine common line practices for patients managed on peripheral ECMO. Responses were obtained from 45 countries with the majority from the United States (n = 181) and United Kingdom (n = 32). Standardised infection precautions including hand hygiene, maximal barrier precautions and skin antisepsis were commonplace for cannulation. The most common antisepsis strategies included alcohol-based chlorhexidine gluconate (CHG) for cannula insertion (53%) and maintenance (54%), isopropyl alcohol on circuit access ports (39%), and CHG-impregnated dressings to cover insertion sites (36%). Adverse patient events due to line malposition or dislodgement were reported by 34% of respondents with most attributable to ineffective securement. Centres ‘always’ suturing peripheral cannula sites were more likely to experience a cannula adverse event than centres that ‘never’ sutured (35% [95% CI 30, 41] vs 0% [95% CI 0, 28]; Chi-square 4.40; p = 0.04) but this did not meet the a priori significance level of <0.01. An evidence-based guideline would be beneficial to improve ECMO line management according to 78% of respondents. Evidence gaps were identified for antiseptic agents, dressing products and regimens, securement methods, and needleless valves. Future research addressing these areas may provide opportunities for consensus guideline development and practice improvement.

Klíčová slova:

Adverse events – Alcohols – Blood – Drug administration – Hygiene – Pediatrics – Respiratory infections – Surveys


Zdroje

1. Allou N, Pinto HL, Persichini R, Bouchet B, Braunberger E, Lugagne N, et al. Cannula-related infection in patients supported by peripheral ECMO: Clinical and microbiological characteristics. ASAIO Journal. 2019;65(2):180–6. doi: 10.1097/MAT.0000000000000771 29517513

2. Conrad SA, Grier LR, Scott LK, Green R, Jordan M. Percutaneous cannulation for extracorporeal membrane oxygenation by intensivists: A retrospective single-institution case series. Critical Care Medicine. 2015;43(5):1010–5. doi: 10.1097/CCM.0000000000000883 25746749

3. Butt W, Heard M, Peek GJ. Clinical management of the extracorporeal membrane oxygenation circuit. Pediatric Critical Care Medicine. 2013;14(5):S13–S9.

4. Belohlavek J, Rohn V, Tosovsky J, Kunstyr J, Semrad M, Horak J, et al. A review of a newly established ECMO program in a university affiliated cardiac center. Journal of Cardiovascular Surgery. 2011;52(3):445–51. 21577197

5. Lindskov C, Jensen RH, Sprogoe P, Klaaborg E, Kirkegaard H, Severinsen IK, et al. Extracorporeal membrane oxygenation in adult patients with severe acute respiratory failure. Acta Anaesthesiologica Scandinavica. 2013;57(3):303–11. doi: 10.1111/aas.12050 23278552

6. Aubron C, Cheng AC, Pilcher D, Leong T, Magrin G, Cooper DJ, et al. Infections acquired by adults who receive extracorporeal membrane oxygenation: Risk factors and outcome. Infection Control and Hospital Epidemiology. 2013;34(1):24–30. doi: 10.1086/668439 23221189

7. Bizzarro MJ, Conrad SA, Kaufman DA, Rycus P. Infections acquired during extracorporeal membrane oxygenation in neonates, children, and adults. Pediatric Critical Care Medicine. 2011;12(3):277–81. doi: 10.1097/PCC.0b013e3181e28894 20495508

8. Burket JS, Bartlett RH, Vender Hyde K, Chenoweth CE. Nosocomial infections in adult patients undergoing extracorporeal membrane oxygenation. Clinical Infectious Diseases. 1999;28(4):828–33. doi: 10.1086/515200 10825046

9. Hsu M-S, Chiu K-M, Huang Y-T, Kao K-L, Chu S-H, Liao C-H. Risk factors for nosocomial infection during extracorporeal membrane oxygenation. Journal of Hospital Infection. 2009;73(3):210–6. doi: 10.1016/j.jhin.2009.07.016 19782430

10. Sun H-Y, Ko W-J, Tsai P-R, Sun C-C, Chang Y-Y, Lee C-W, et al. Infections occurring during extracorporeal membrane oxygenation use in adult patients. The Journal of Thoracic and Cardiovascular Surgery. 2010;140(5):1125–32. doi: 10.1016/j.jtcvs.2010.07.017 20708754

11. Douglass BH, Keenan AL, Purohit DM. Bacterial and fungal infection in neonates undergoing venoarterial extracorporeal membrane oxygenation: An analysis of the registry data of the extracorporeal life support organization. Artificial Organs. 1996;20(3):202–8. doi: 10.1111/j.1525-1594.1996.tb04428.x 8694690

12. Meyer DM, Jessen ME, Eberhart RC. Neonatal extracorporeal membrane oxygenation complicated by sepsis. Extracorporeal Life Support Organization. Tha Annals of Thoracic Surgery. 1995;59(4):975–80.

13. Montgomery VL, Strotman JM, Ross MP. Impact of multiple organ system dysfunction and nosocomial infections on survival of children treated with extracorporeal membrane oxygenation after heart surgery. Critical Care Medicine. 2000;28(2):526–31. doi: 10.1097/00003246-200002000-00040 10708195

14. Biffi S, Di Bella S, Scaravilli V, Peri AM, Grasselli G, Alagna L, et al. Infections during extracorporeal membrane oxygenation: Epidemiology, risk factors, pathogenesis and prevention. International Journal of Antimicrobial Agents. 2017;50(1):9–16. doi: 10.1016/j.ijantimicag.2017.02.025 28528989

15. Messika J, Schmidt M, Aubry A, Combes A, Ricard J-D. Extracorporeal membrane oxygenation-associated infections: Carefully consider cannula infection. Critical Care Medicine. 2018;46(2):e171–e2.

16. Australia and New Zealand Extracorporeal Membrane Oxygenation (ANZ ECMO) Investigators, Davies A, Jones D, Bailey M, Beca J, Bellomo R, et al. Extracorporeal membrane oxygenation for 2009 influenza A(H1N1) acute respiratory respiratory distress syndrome. JAMA. 2009;302(17):1888–95. doi: 10.1001/jama.2009.1535 19822628

17. Combes A, Leprince P, Luyt CE, Bonnet N, Trouillet J-L, Leger P, et al. Outcomes and long-term quality of life of patients supported by extracorporeal membrane oxygenation for refractory cardiogenic shock. Critical Care Medicine. 2008;36(5):1404–11. doi: 10.1097/CCM.0b013e31816f7cf7 18434909

18. Schmidt M, Bréchot N, Hariri S, Guiguet M, Luyt CE, Makri R, et al. Nosocomial infections in adult cardiogenic shock patients supported by venoarterial extracorporeal membrane oxygenation. Clinical Infectious Diseases. 2012;55(12):1633–41. doi: 10.1093/cid/cis783 22990851

19. Hahne K, Horstmann C, Fischer D, Kock R, Peters G, Lebiedz P. Cannula-related infection in adult medical intensive care unit patients undergoing extracorporeal life support and extracorporeal membrane oxygenation. Journal of Hospital Infection. 2015;91(4):372–3. doi: 10.1016/j.jhin.2015.08.022 26518270

20. Extracorporeal Life Support Organization. ELSO guidelines for cardiopulmonary extracorporeal life support, Version 1.4. Ann Arbor, MI, USA: Extracorporeal Life Support Organisation; 2017 [cited 2018 Mar 19]. Available from: https://www.elso.org/Resources/Guidelines.aspx.

21. Glater-Welt LB, Schneider JB, Zinger MM, Rosen L, Sweberg TM. Nosocomial bloodstream infections in patients receiving extracorporeal life support: Variability in prevention practices: a survey of the extracorporeal life support organization members. Journal of Intensive Care Medicine. 2016;31(10):654–9. doi: 10.1177/0885066615571540 25670726

22. Extracorporeal Life Support Organization Infectious Disease Task Force. Infection control and extracorporeal life support; 2012 [cited 2018 Mar 19]. Available from: https://www.elso.org/AboutUs/TaskForces/InfectiousDiseaseTaskForce.aspx.

23. Gwet KL. Computing inter-rater realiability and its variance in the presence of high agreement. British Journal of Mathematical and Statistical Psychology. 2008;61(Pt 1):29–48. doi: 10.1348/000711006X126600 18482474

24. Klein D. "KAPPAETC: stata module to evaluate interrater agreement", Statistical Software Components S458283. Boston College Department of Economics; 2016 [updated 2018 Feb 1; cited 2018 Sep 5]. Available from: https://ideas.repec.org/c/boc/bocode/s458283.html.

25. O'Grady NP, Alexander M, Burns LA, Dellinger EP, Garland J, Heard SO, et al. Guidelines for the prevention of intravascular catheter-related infections. American Journal of Infection Control. 2011;39(4 Suppl 1):S1–34.

26. Loveday HP, Wilson JA, Pratt RJ, Golsorkhi M, Tingle A, Bak A, et al. Epic3: national evidence-based guidelines for preventing healthcare-associated infections in NHS hospitals in England. Journal of Hospital Infection. 2014;86(Suppl 1):S1–S70.

27. Yokoe DS, Anderson DJ, Berenholtz SM, Calfee DP, Dubberke ER, Ellingson KD, et al. A compendium of strategies to prevent healthcare-associated infections in acute care hospitals: 2014 updates. American Journal of Infection Control. 2014;42(8):820–8. doi: 10.1016/j.ajic.2014.07.002 25087135

28. Moreau NL, Flynn J. Disinfection of needleless connector hubs: clinical evidence systematic review. Nursing Research and Practice. 2015. doi: 10.1155/2015/796762 26075093. PubMed Central PMCID: PMC4446481.

29. Lai NM, Lai NA, O'Riordan E, Chaiyakunapruk N, Taylor JE, Tan K. Skin antisepsis for reducing central venous catheter-related infections. Cochrane Database of Systematic Reviews. 2016. doi: 10.1002/14651858.CD010140.pub2 27410189. PubMed Central PMCID: PMC6457952.

30. Niles SD, Ploessl J, Sutton PG, Steinberg JB. Oxygenator failure due to contact with bathing alcohol: A case report. Journal of Extra-corporeal Technology. 1992;24(2):69–71.

31. Gorski L, Hadaway L, Hagle ME, McGoldrick M, Orr M, Doellman D. Infusion therapy standards of practice. Journal of Infusion Nursing. 2016;29(1S):S1–S159.

32. Thomas G, Hraiech S, Cassir N, Lehingue S, Rambaud R, Wiramus S, et al. Venovenous extracorporeal membrane oxygenation devices-related complications and infections. Annals of Intensive Care. 2017;7:111. doi: 10.1186/s13613-017-0335-9 29116464; PubMed Central PMCID: PMC5676570.

33. Na SJ, Chung CR, Choi HJ, Cho YH, Yang JH, Suh GY, et al. Bloodstream infection in patients on venovenous extracorporeal membrane oxygenation for respiratory failure. Infection Control and Hospital Epidemiology. 2018;39(7):871–4. doi: 10.1017/ice.2018.90 29733005

34. Timsit JF, Mimoz O, Mourvillier B, Souweine B, Garrouste-Orgeas M, Alfandari S, et al. Randomized controlled trial of chlorhexidine dressing and highly adhesive dressing for preventing catheter-related infections in critically ill adults. American Journal of Respiratory and Critical Care Medicine. 2012;186(12):1272–8. doi: 10.1164/rccm.201206-1038OC 23043083

35. Ullman AJ, Cooke ML, Mitchell M, Lin F, New K, Long DA, et al. Dressing and securement for central venous access devices (CVADs): A Cochrane systematic review. International Journal of Nursing Studies. 2016;59:177–96. doi: 10.1016/j.ijnurstu.2016.04.003 27222463.

36. Jenks M, Craig J, Green W, Hewitt N, Arber M, Sims A. Tegaderm CHG IV securement dressing for central venous and arterial catheter insertion sites: A NICE medical technology guidance. Applied Health Economics and Health Policy. 2016;14(2):135–49. doi: 10.1007/s40258-015-0202-5 26458938

37. Schwebel C, Lucet JC, Vesin A, Arrault X, Calvino-Gunther S, Bouadma L, et al. Economic evaluation of chlorhexidine-impregnated sponges for preventing catheter-related infections in critically ill adults in the dressing study. Critical Care Medicine. 2012;40(1):11–7. doi: 10.1097/CCM.0b013e31822f0604 21926570

38. Combes A, Brodie D, Chen YS, Fan E, Henriques JPS, Hodgson C, et al. The ICM research agenda on extracorporeal life support. Intensive Care Med. 2017;43(9):1306–18. doi: 10.1007/s00134-017-4803-3 28470346

39. Inwood I. An exploration of the past, present and future of catheter securement. British Journal of Nursing. 2014;23(8):S26–S7. doi: 10.12968/bjon.2014.23.Sup8.S26 24763271

40. Kao LS, Fleming GM, Escamilla RJ, Lew DF, Lally KP. Antimicrobial prophylaxis and infection surveillance in extracorporeal membrane oxygenation patients: A multi-institutional survey of practice patterns. ASAIO Journal. 2011;57(3):231–8. doi: 10.1097/MAT.0b013e31820d19ab 21317768


Článek vyšel v časopise

PLOS One


2019 Číslo 12